• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意大利帕金森病患者中LRRK2 G2019S突变的频率和表型

Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease.

作者信息

Marongiu Roberta, Ghezzi Daniele, Ialongo Tamara, Soleti Francesco, Elia Antonio, Cavone Stefania, Albanese Alberto, Altavista Maria Concetta, Barone Paolo, Brusa Livia, Cortelli Pietro, Petrozzi Lucia, Scaglione Cesa, Stanzione Paolo, Tinazzi Michele, Zeviani Massimo, Dallapiccola Bruno, Bentivoglio Anna Rita, Valente Enza Maria, Garavaglia Barbara

机构信息

IRCCS CSS, Mendel Institute, Rome.

出版信息

Mov Disord. 2006 Aug;21(8):1232-5. doi: 10.1002/mds.20890.

DOI:10.1002/mds.20890
PMID:16622859
Abstract

To evaluate the frequency of the LRRK2 G2019S mutation in Italy, we tested 1,072 probands with Parkinson's disease (PD; 822 sporadic and 250 familial): 20 patients (1.9%) carried the G2019S mutation, 11 patients (1.3%) were sporadic, and 9 (4.3%) had a positive family history. Considering only probands with autosomal dominant inheritance, the G2019S frequency raises to 5.2%. All presented a typical phenotype with variable onset and shared the common ancestral haplotype. Mutation frequency raised from 1.2% in early onset PD to 4.0% in late onset PD.

摘要

为评估意大利LRRK2基因G2019S突变的频率,我们检测了1072例帕金森病(PD)先证者(822例散发性和250例家族性):20例患者(1.9%)携带G2019S突变,其中11例(1.3%)为散发性,9例(4.3%)有家族史阳性。仅考虑常染色体显性遗传的先证者,G2019S频率升至5.2%。所有患者均表现出典型的发病可变的表型,并共享常见的祖先单倍型。突变频率从早发型PD的1.2%升至晚发型PD的4.0%。

相似文献

1
Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease.意大利帕金森病患者中LRRK2 G2019S突变的频率和表型
Mov Disord. 2006 Aug;21(8):1232-5. doi: 10.1002/mds.20890.
2
A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.俄罗斯家族性和散发性帕金森病中常见的富含亮氨酸重复序列激酶2基因突变。
Eur J Neurol. 2007 Apr;14(4):413-7. doi: 10.1111/j.1468-1331.2007.01685.x.
3
Frequency of the LRRK2 G2019S mutation in Italian patients affected by Parkinson's disease.意大利帕金森病患者中LRRK2 G2019S突变的频率。
J Hum Genet. 2007;52(3):201-204. doi: 10.1007/s10038-006-0105-2. Epub 2007 Jan 18.
4
Genetic analysis for five LRRK2 mutations in a Sardinian parkinsonian population: importance of G2019S and R1441C mutations in sporadic Parkinson's disease patients.撒丁岛帕金森病患者群体中五个LRRK2突变的基因分析:G2019S和R1441C突变在散发性帕金森病患者中的重要性
Parkinsonism Relat Disord. 2009 May;15(4):277-80. doi: 10.1016/j.parkreldis.2008.06.009. Epub 2008 Sep 20.
5
The G2019S LRRK2 mutation is uncommon amongst Greek patients with sporadic Parkinson's disease.G2019S型LRRK2基因突变在希腊散发性帕金森病患者中并不常见。
Eur J Neurol. 2007 Oct;14(10):1088-90. doi: 10.1111/j.1468-1331.2007.01867.x.
6
The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor.LRRK2基因中的G6055A(G2019S)突变在早发性和晚发性帕金森病中均很常见,且源自一个共同祖先。
J Med Genet. 2005 Nov;42(11):e65. doi: 10.1136/jmg.2005.035568.
7
G2019S LRRK2 mutation in familial and sporadic Parkinson's disease in Russia.俄罗斯家族性和散发性帕金森病中的G2019S LRRK2突变
Mov Disord. 2006 Dec;21(12):2234-6. doi: 10.1002/mds.21134.
8
Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.早发型和晚发型帕金森病中LRRK2突变的频率
Neurology. 2006 Nov 28;67(10):1786-91. doi: 10.1212/01.wnl.0000244345.49809.36. Epub 2006 Oct 18.
9
LRRK2 G2019S is a common mutation in Spanish patients with late-onset Parkinson's disease.LRRK2基因G2019S突变在西班牙晚发性帕金森病患者中是一种常见突变。
Neurosci Lett. 2006 Mar 13;395(3):224-6. doi: 10.1016/j.neulet.2005.10.083. Epub 2005 Nov 18.
10
The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?患有帕金森病的阿什肯纳兹犹太人中LRRK2基因G2019S突变:是否存在性别效应?
Neurology. 2007 Oct 16;69(16):1595-602. doi: 10.1212/01.wnl.0000277637.33328.d8.

引用本文的文献

1
Genetic mutations in Parkinson's disease: screening of a selected population from North-Eastern Italy.帕金森病中的基因突变:对意大利东北部特定人群的筛查
Neurol Sci. 2025 Jan;46(1):165-174. doi: 10.1007/s10072-024-07690-7. Epub 2024 Jul 22.
2
A Comprehensive Analysis of Population Differences in Variant Distribution in Parkinson's Disease.帕金森病变异分布中人群差异的综合分析
Front Aging Neurosci. 2019 Jan 30;11:13. doi: 10.3389/fnagi.2019.00013. eCollection 2019.
3
Successful subthalamic stimulation, but levodopa-induced dystonia, in a genetic Parkinson's disease.
在遗传性帕金森病中,成功地进行了丘脑底核刺激,但出现了左旋多巴诱导的异动症。
Neurol Sci. 2013 Mar;34(3):383-6. doi: 10.1007/s10072-012-1014-0. Epub 2012 Mar 22.
4
The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews.LRRK2 G2019S 突变是导致阿什肯纳兹犹太人帕金森病的原因。
J Neural Transm (Vienna). 2009 Nov;116(11):1473-82. doi: 10.1007/s00702-009-0303-0.
5
Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions.富含亮氨酸重复激酶 2 突变与帕金森病:三个问题。
ASN Neuro. 2009 Apr 14;1(1):e00002. doi: 10.1042/AN20090007.
6
No association between the LRRK2 G2019S mutation and Alzheimer's disease in Italy.在意大利,LRRK2基因G2019S突变与阿尔茨海默病之间无关联。
Cell Mol Neurobiol. 2007 Nov;27(7):877-81. doi: 10.1007/s10571-007-9207-4. Epub 2007 Sep 11.